Latest filing published 02 Oct 2026 for Monopar Therapeutics. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Quan Anh Vu is a declared insider at 2 companies; the most frequent names are Monopar Therapeutics and FORUM MARKETS Inc. We count 5 filings; the first trade dates from 10 December 2021 and the latest from 30 September 2026.
On the market, this insider has only ever bought: 3 purchases, €133k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant and 1 option exercise.
In size, the median ticket on the buying side is €28k. On 2 out of 3 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
The latest filing, published on 2 October 2026, reports an option exercise in Monopar Therapeutics. The latest purchase dates back some time: it was published 293 days ago, on 29 December 2025. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations